AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,805,732 | +373.3% | 254,564 | +160.6% | 0.00% | – |
Q3 2022 | $804,000 | +26.2% | 97,689 | +0.6% | 0.00% | – |
Q2 2022 | $637,000 | +17.3% | 97,089 | 0.0% | 0.00% | – |
Q1 2022 | $543,000 | +30.2% | 97,089 | +9.2% | 0.00% | – |
Q4 2021 | $417,000 | -24.0% | 88,895 | 0.0% | 0.00% | – |
Q3 2021 | $549,000 | -13.3% | 88,895 | -7.4% | 0.00% | – |
Q2 2021 | $633,000 | -72.6% | 95,995 | -69.5% | 0.00% | – |
Q1 2021 | $2,307,000 | +43.6% | 315,187 | +13.3% | 0.00% | – |
Q4 2020 | $1,606,000 | +41.6% | 278,267 | +45.7% | 0.00% | – |
Q3 2020 | $1,134,000 | +67.5% | 190,934 | +45.2% | 0.00% | – |
Q2 2020 | $677,000 | – | 131,510 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |